By Izzy Wood (Drug Target Review)2023-04-28T15:00:49
Progress in identifying the gene responsible for facial and skull changes in mouse model of Down Syndrome, made by UK researchers.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud